Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
The 'Make Sense Campaign' for head and neck cancer awareness
Prof René Leemans - General Secretary of the European Head and Neck Society
The 'Make Sense Campaign' for head and neck cancer awareness ( Prof René Leemans - General Secretary of the European Head and Neck Society )
2 Oct 2013
Highlights of the ALATRO 2013 conference
Dr Luis Pinillos - ALATRO 2013 Vice-President, Lima, Peru
Highlights of the ALATRO 2013 conference ( Dr Luis Pinillos - ALATRO 2013 Vice-President, Lima, Peru )
15 Aug 2013
ECC 2013 Preview: Scientific programme highlights
Prof Vincenzo Valentini and Ian Banks
ECC 2013 Preview: Scientific programme highlights ( Prof Vincenzo Valentini and Ian Banks )
11 Jul 2013
Science behind phase I clinical trials: targeting tumour cell development pathwa...
Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA
Science behind phase I clinical trials: targeting tumour cell development pathways ( Dr Gary K. Schwartz - Memorial Sloan-Kettering Cancer Center, New York, USA )
6 Jun 2013
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer
Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - University of Pennsylvania, Philadelphia, USA )
2 Jun 2013
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer
Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA
Sorafenib stalls growth of treatment-resistant differentiated thyroid cancer ( Dr Marcia Brose - Abramson Cancer Center, University of Pennsylvania, USA )
2 Jun 2013
New MEK inhibitor selumetinib is the first effective drug for advanced melanoma ...
Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA
New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye ( Dr Richard D. Carvajal - Memorial Sloan-Kettering Cancer Center, New York, USA )
1 Jun 2013
Next generation PI3 kinase inhibition
Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US
Next generation PI3 kinase inhibition ( Dr Maurizio Scaltriti – Massachusetts General Hospital, Boston, MA, US )
19 Apr 2013
Targeting tumour suppressor genes
Dr Douglas Lowy - National Cancer Institute, Bethesda, USA
Targeting tumour suppressor genes ( Dr Douglas Lowy - National Cancer Institute, Bethesda, USA )
19 Apr 2013
Robotic oesophagectomy
Dr Kemp Kernstine - University of Texas Southwestern Medical Center, United Stat...
Robotic oesophagectomy  ( Dr Kemp Kernstine - University of Texas Southwestern Medical Center, United States )
19 Dec 2012
Benefits of partaking in clinical trials
Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National...
Benefits of partaking in clinical trials ( Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National Cancer Peer Review, UK  )
15 Nov 2012
Analysing the efficacy of treatment through Response Evaluation Criteria in Soli...
Dr Yves Menu – Saint Antoine Hospital, Paris, France
Analysing the efficacy of treatment through Response Evaluation Criteria in Solid Tumors (RECIST) ( Dr Yves Menu – Saint Antoine Hospital, Paris, France )
9 Oct 2012